Received Aug 4, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MNQ | MENINGOCOCCAL CONJUGATE (MENVEO) | NOVARTIS VACCINES AND DIAGNOSTICS | UNK | E4A39 | — |
Administration to a 2-year-old patient; This non-serious case was reported by a other health professional via call center representative and described the occurrence of inappropriate age at vaccine administration in a 2-year-old female patient who received Men ACWY-CRM NVS (Menveo) (batch number E4A39) for prophylaxis. On 16-MAY-2025, the patient received Menveo. On 16-MAY-2025, an unknown time after receiving Menveo, the patient experienced inappropriate age at vaccine administration (Verbatim: Administration to a 2-year-old patient). The outcome of the inappropriate age at vaccine administration was not applicable. Additional Information: GSK receipt date: 17-JUL-2025 Other HCP needed to verify if the Menveo that they had was the 1 vial or 2 vials. They just wanted to see what was given to the patient. Patient's age at vaccination was 2 years, which led to inappropriate age at vaccine administration.